About ProGen Advance Insilico Solutions
Transforming complex biological data into meaningful, publication-quality scientific insights through advanced bioinformatics, structural modeling, and artificial intelligence.
Dedicated to Accelerating Life Science Discovery
ProGen Advance Insilico Solutions LLP is a research-focused bioinformatics and computational biology enterprise committed to accelerating scientific discovery through advanced computational solutions.
Our multidisciplinary team of bioinformaticians, computational biologists, AI specialists, and data scientists partners with academic institutions, biotechnology companies, pharmaceutical organizations, and healthcare researchers to transform complex biological data into meaningful scientific insights.
We provide end-to-end computational support spanning drug discovery, structural biology, multi-omics analysis, artificial intelligence, and custom bioinformatics solutions, enabling researchers to make informed decisions with confidence.
Mission & Vision
Guided by scientific purpose, ethical data stewardship, and technological innovation.
Our Mission
To empower life sciences research by delivering accessible, reliable, and affordable bioinformatics solutions that accelerate innovation and scientific excellence.
We believe that powerful computational tools should not be restricted by institutional barriers. We partner closely with researchers to convert hypotheses into validated in silico findings.
Our Vision
To become a globally trusted partner for computational biology, bioinformatics, and AI-driven research by enabling impactful scientific discoveries through collaboration, innovation, and integrity.
Creating an ecosystem where biological complexity is systematically de-risked and translated into tangible therapeutics and precision diagnostics.
Scientific Integrity, Confidentiality & Rigor
Every computational workflow conducted at ProGen adheres to uncompromising standards of transparency, data privacy, and scientific reproducibility.
Strict Confidentiality & NDAs
We protect proprietary targets, novel chemical structures, and unpublished sequencing datasets under comprehensive Non-Disclosure Agreements (NDAs). Your intellectual property remains exclusively yours.
Reproducible Computational Science
All docking coordinates, simulation force-field parameters, random seeds, and pipeline scripts are fully documented, allowing peer reviewers or internal discovery teams to independently reproduce every finding.
Transparent Experimental Boundaries
We explicitly differentiate between predictive in silico findings and wet-lab experimental validation. We never claim clinical outcomes or in vitro affinity without collaborative enzymatic or cell-based data.